埃文教授正在领头研究有关三苯氧胺（一种抗肿瘤药）的使用，该药可以将乳腺癌的危险性减小40%。
Prof Evans is leading a study into the use of the drug tamoxifen, which may reduce the risk of breast cancer by 40 per cent.
之后，她服用抗雌激素的三苯氧胺长达五年。
After that, she is put on the anti-estrogen Tamoxifen for five years.
三苯氧胺是第一个雌激素调节剂，可增加患者的生存率和降低乳腺癌复发的危险。
Tamoxifen was the first estrogen modulator shown to increase survival and reduce the risk of breast cancer recurrence.
应用推荐